NCT05305365
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05305365
Title Study Assessing QBS72S For Treating Brain Metastases
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Melanie Hayden Gephart
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.